1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Next deadline: March 9, 2026. Two tracks: PAR-24-114 (clinical trial required) and PAR-24-113 (clinical trial not allowed).
International Research Scientist Development Award (IRSDA) is sponsored by NIH Fogarty International Center. The International Research Scientist Development Award (IRSDA) supports US scientists who are early in their career to conduct mentored research in a low- or middle-income country (LMIC).
While the prompt specifies Europe, some European countries are classified as LMICs, making this potentially relevant for international research experience.
Get alerted about grants like this
Save a search for “NIH Fogarty International Center” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
International Research Scientist Development Award (IRSDA) (K01) - Fogarty International Center @ NIH International Research Scientist Development Award International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required ) (PAR-24-114) International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed (PAR-24-113) Upcoming application due dates: Some current and former NIH PDs/PIs are not eligible.
Applicants must be U.S. citizens or permanent residents who hold a research or health-professional doctoral degree and have at least two years of research experience beyond receipt of their doctoral degree. Individuals who are have already received independent research funding are not eligible for the IRSDA. Candidates are required to have both U.S. and LMIC primary mentors.
Candidates are required to spend a minimum of 50 percent of the total project period physically in-country conducting research at the LMIC institution. Applicants should demonstrate that they are committed to an independent research career in global health, and justify the need for three to five years of mentored research experience in order to become an independent research scientist.
Eligibility details for PAR-24-114 independent clinical trial required Eligibility details for PAR-24-113 clinical trial not allowed IRSDA frequently asked questions (FAQs) International Research Scientist Development Award (IRSDA) provides support and protected time (three to five years) to advanced postdoctoral U.S. research scientists and recently-appointed U.S. junior faculty (applicants must be at least two years beyond conferral of doctoral degree) for an intensive, mentored research career development experience.
The experience will be in a low- or middle-income country (LMIC) as defined by the World Bank . Low-income, lower-middle-income and upper-middle-income countries are included. Applications are invited from early career investigators from any health-related discipline who propose career development activities and a research project that is related to the health priorities of the LMIC.
View a full list of International Research Scientist Development Awards by principal investigator. Frequently Asked Questions Review answers to frequently asked questions about the International Research Scientist Development Award (IRSDA). Fogarty International Center National Institutes of Health Email (preferred): Christine.
Jessup@nih. gov Grants Management Specialist Fogarty International Center National Institutes of Health 31 Center Drive, MSC 2220 Email: Mollie. Shea@nih.
gov The announcements related to this program are issued by Fogarty in collaboration with the following NIH Institutes: National Cancer Institute (NCI) National Institute on Deafness and Other Communication Disorders (NIDCD) These UCLA surgeons are redefining global health Culturally relevant meal plans lead to better health Facilitators and barriers to home blood pressure monitoring among pregnant women in Ghana: a mixed-methods analysis of patient perspectives , co-authored by Fogarty International Research Scientist Emma Lawrence BMC Pregnancy and Childbirth , March 19, 2024 Performance of a stool-based quantitative PCR assay for the diagnosis of tuberculosis in adolescents and adults: a multinational, prospective diagnostic accuracy study , co-authored by Fogarty International Research Scientist Alexander Kay The Lancet Microbe , March 7, 2024 Development, acceptability and usability of culturally appropriate survivor narrative videos for breast cancer treatment in Botswana: a pilot study , co-authored by Fogarty International Research Scientist Yehoda M.
Martei Utilizing river and wastewater as a SARS-CoV-2 surveillance tool in settings with limited formal sewage systems , co-authored by Fogarty International Research Scientist Kayla G.
Barnes Nature Communications , November 30, 2023 Researchers probe HIV-associated stroke in Zambia A quest for molecular and agricultural solutions to prevent konzo Addressing mental health abroad helps US communities Oral health researchers welcome here! – Opinion by Fogarty Director Dr. Roger I.
Glass IRSDA grantee studies the moringa plant’s medicinal, nutritional benefits Fogarty awards $10M for early-career researchers to establish independent careers in global health Children in developing countries can benefit from proton therapy medicalphysicsweb, Feb 22, 2018 Early-career scientists receive $3.
3M to help establish independent research careers Focus on IRSDA: investment in early-career scientists pays off Untangled web: Mapping environmental, economic and health factors may point the way to sustainable development Harvard Medical School news, Aug 7, 2017 Expired funding announcement: International Research Scientist Development Award (IRSDA) (K01) (PAR-17-002) , released October 4, 2016 New awards provide mentored career development for promising global health researchers Fogarty news, Jan 31, 2017 Child dehydration diagnostic tool validated New career development program launched for LMIC scientists International Research Scientist Development Award (IRSDA) (K01) (PAR-15-291) , released July 7, 2015 University of Georgia researcher receives NIH grant to improve women's health in Liberia Athens Banner-Herald , Oct 22, 2013 International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed (PAR-21-104) Archive: Grants awarded through PAR-21-104 in NIH RePORTER International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Required (PAR-21-105) Archive: Grants awarded through PAR-21-105 in NIH RePORTER International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed ( PAR-18-539 ) International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Required ( PAR-18-540 ) International Research Scientist Development Award (IRSDA) (PAR-13-072) (K01) - January 2013 Grants awarded through PAR-13-072 in NIH RePORTER International Research Scientist Development Award (IRSDA) (PAR-10-066) (K01) - December 2009 Grants awarded through PAR-10-066 in NIH RePORTER International Research Scientist Development Award (IRSDA) (PAR-07-014) (K01) - October 2006 Grants awarded through PAR-07-014 in NIH RePORTER International Research Scientist Development Award (IRSDA) (PAR-04-058) (K01) - February 2004 Grants awarded through PAR-04-058 in NIH RePORTER International Research Scientist Development Award (IRSDA) (PAR-02-041) (K01) - December 2001 Grants awarded through PAR-02-041 in NIH RePORTER Notice of the National Cancer Institute (NCI) Participation in PAR-15-291 "International Research Scientist Development Award (IRSDA) (K01)" (NOT-CA-16-002) , released December 22, 2015 Notice of Intent to Publish a Funding Opportunity to Reissue PAR-10-066, the International Research Scientist Development Award (IRSDA) Program (K01) , released September 7, 2012
Based on current listing details, eligibility includes: US citizens or permanent residents with a doctoral degree and early-career scientists. Must propose research in an LMIC. Not specific to surgery, but can support health-related research. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is March 9, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
Mobile Health (mHealth) is a grant from the NIH Fogarty International Center that funds exploratory and developmental research on innovative mobile health interventions and tools designed for low- and middle-income countries (LMICs). The R21/R33 program supports up to two years of technology development and feasibility studies (R21 phase), with possible transition to larger validation and effectiveness studies (R33 phase). Eligible projects must use new or emerging mobile and wireless technology; SMS-only interventions are not eligible. US institutions must involve LMIC researchers as key personnel. LMIC institutions may apply independently or with US partners. This grant is issued by Fogarty in collaboration with multiple NIH institutes including NCI, NIMH, NIBIB, and NICHD. Award amounts vary based on phase and scope.
LAUNCHing Leaders for Future U.S. Investments in Global Health Research is a grant from NIH Fogarty International Center (RFA-TW-25-002) that funds international research training programs to build global health research capacity in low- and middle-income countries. The D43 training grant mechanism supports structured programs at universities that develop the next generation of global health researchers and strengthen partnerships with U.S. institutions. The program advances U.S. investments in global health by building a pipeline of highly trained international investigators. Eligible applicants are universities in low- and middle-income countries partnering with U.S. institutions. The estimated application deadline is May 25, 2026.
Research Council of Finland (RCF) – National Institutes of Health (NIH) Partnership Program (PA-26-085) is a grant from NIH's Fogarty International Center that funds collaborative health research projects between U.S. and Finnish universities. The program supports joint research initiatives in health sciences, with award decisions forecasted for April 2027 and an estimated application deadline of June 5, 2026. Eligible applicants include public and private institutions of higher education, nonprofits with 501(c)(3) status, for-profit organizations, independent school districts, and other entities. No cost sharing or matching requirement applies to this grant.
EPAs SmartWay Transport Partnership and National Clean Diesel Campaign (NCDC) are announcing the availability of funding assistance to create finance programs, such as low cost leases or revolving loan programs, to achieve significant reductions in diesel emissions throughout the United States. The SmartWay Clean Diesel Finance Program is soliciting proposals for projects that reduce diesel emissions through the creation of national, tribal, regional, state or local finance program(s). Finance programs include, but are not limited to, those that provide the loan recipient a specific financial incentive (i.e., longer terms or lower rates) to purchase or lease eligible retrofitted vehicles or equipment. The proposed finance program should maximize the total project funds available for financing eligible diesel emission reduction solutions and be sustainable to maintain the program. Funding Opportunity Number: EPA-OAR-OTAQ-09-13. Assistance Listing: 66.039. Funding Instrument: CA. Category: ENV. Award Amount: $2M – $12M per award.
The U. S. Environmental Protection Agency Region 2 is soliciting applications for projects that address the 2010 Reduce, Reuse, Recycle, Rebuy (4Rs) in Schools Program goals from applicants carrying out or desiring to carry out projects that serve EPA Region 2: New York, New Jersey, Puerto Rico, and Virgin Islands. Applicantsare required to be members of, or to join, EPAs WasteWise program in order to apply.See subsection E for more information. Funding Opportunity Number: EPA-R2-RPB-01-2010. Assistance Listing: 66.808. Funding Instrument: CA. Category: ENV. Award Amount: $60K total program funding.
The Healthy Communities Grant Program is seeking projects that: Target resources to benefit communities at risk (environmental justice areas of potential concern, places with high risk from toxic air pollution, urban areas) and sensitive populations (e.g. children, elderly, others at increased risk). Assess, understand, and reduce environmental and human health risks. Increase collaboration through community-based projects. Build institutional and community capacity to understand and solve environment and human health problems. Achieve measurable environmental and human health benefits. Proposed projects must: (1) Be located in and/or directly benefit one or more of the three Target Investment Areas which include: Environmental Justice Areas of Potential Concern, Sensitive Populations, and/or Urban Areas in one or more of the EPA Region I States of Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and/or Vermont; and (2) Identify how the proposed project will achieve measurable environmental and/or public health results in one or more of the five Target Program Areas which include Asthma, Capacity Building on Environmental and Public Health Issues, Healthy Indoor/Outdoor Environments, Healthy Schools, Urban Natural Resources. Funding Opportunity Number: EPA-R1-HC-2010. Assistance Listing: 66.110. Funding Instrument: CA. Category: ENV. Award Amount: $5K – $35K per award.